These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 576533)

  • 21. Plasma ACTH and cortisol profiles in Addisonian patients receiving conventional substitution therapy.
    Scott RS; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1978 Dec; 9(6):571-6. PubMed ID: 218754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of adrenal cortical dysfunction by liquid chromatography-tandem mass spectrometry.
    Kao PC; Machacek DA; Magera MJ; Lacey JM; Rinaldo P
    Ann Clin Lab Sci; 2001 Apr; 31(2):199-204. PubMed ID: 11337910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements.
    Arlt W; Rosenthal C; Hahner S; Allolio B
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):384-9. PubMed ID: 16584509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does recovery of adrenal function occur in patients with autoimmune Addison's disease?
    Smans LC; Zelissen PM
    Clin Endocrinol (Oxf); 2011 Apr; 74(4):434-7. PubMed ID: 21114513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of thyrotropin excess in untreated primary adrenal insufficiency.
    Topliss DJ; White EL; Stockigt JR
    J Clin Endocrinol Metab; 1980 Jan; 50(1):52-6. PubMed ID: 6765953
    [No Abstract]   [Full Text] [Related]  

  • 26. Urine free-cortisol determination. A useful tool in the management of chronic hypoadrenal states.
    Burch WM
    JAMA; 1982 Apr; 247(14):2002-4. PubMed ID: 7062507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the question of cortisol administration in adrenocortical insufficiency (author's transl)].
    August S; LeBlanc S; von zur Mühlen A; Hesch RD
    Dtsch Med Wochenschr; 1979 Apr; 104(14):506-10. PubMed ID: 436613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in cortisol metabolism following rifampicin therapy.
    Edwards OM; Courtenay-Evans RJ; Galley JM; Hunter J; Tait AD
    Lancet; 1974 Sep; 2(7880):548-51. PubMed ID: 4140269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pregnancy and Addison's disease.
    Khunda S
    Obstet Gynecol; 1972 Mar; 39(3):431-4. PubMed ID: 5019317
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial congenital adrenal hypoplasia.
    Uttley WS
    Arch Dis Child; 1968 Dec; 43(232):724-30. PubMed ID: 5702234
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of decreased adrenal corticosteroids: changes in sleep in normal subjects and patients with adrenal cortical insufficiency.
    Gillin JC; Jacobs LS; Snyder F; Henkin RI
    Electroencephalogr Clin Neurophysiol; 1974 Mar; 36(3):283-9. PubMed ID: 4130607
    [No Abstract]   [Full Text] [Related]  

  • 34. Natural History of Adrenal Steroidogenesis in Autoimmune Addison's Disease Following Diagnosis and Treatment.
    Napier C; Allinson K; Gan EH; Mitchell AL; Gilligan LC; Taylor AE; Arlt W; Pearce SHS
    J Clin Endocrinol Metab; 2020 Jul; 105(7):2322-30. PubMed ID: 32300791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M; Gryczyńska M; Sowińska A; Sowiński J
    Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent hypersecretion of ACTH in treated Addison's disease.
    Child DF; Lewis F; Williams CP
    J R Soc Med; 1990 Jun; 83(6):399-400. PubMed ID: 2166161
    [No Abstract]   [Full Text] [Related]  

  • 37. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison's Disease.
    Ross IL; Lacerda M; Pillay TS; Blom DJ; Johannsson G; Dave JA; Levitt NS; Haarburger D; van der Walt JS
    Horm Metab Res; 2016 Dec; 48(12):814-821. PubMed ID: 27813051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in three daily doses.
    Laureti S; Falorni A; Santeusanio F
    J Endocrinol Invest; 2003 Nov; 26(11):1071-5. PubMed ID: 15008243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulins of patients with idiopathic Addison's disease block the in vitro action of adrenocorticotropin.
    Wulffraat NM; Drexhage HA; Bottazzo GF; Wiersinga WM; Jeucken P; Van der Gaag R
    J Clin Endocrinol Metab; 1989 Aug; 69(2):231-8. PubMed ID: 2546959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic interpretation of plasma cortisol and cortisone concentrations following a signle oral administration of cortisone acetate to human subjects.
    Colburn WA; DiSanto AR; Stubbs SS; Monovich RE; DeSante KA
    J Clin Pharmacol; 1980 Jul; 20(7):428-36. PubMed ID: 7430411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.